LicianPro

Cytek Biosciences, Inc. ·

CTKB 8-K 2026-09-29

Cytek Biosciences, Inc. (CTKB) 8-K dated 2026-09-29 — accession 0001193125-26-407330.

Cytek Biosciences, Inc. (CTKB) is a medical devices company listed on US.

Cytek Biosciences, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407330.

This 8-K covers: Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CTKB revenue for 2025-12-31 was $201.5M. Net income was -$66.5M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. CTKB currently screens at market cap $421.8M.

Not investment advice. The CTKB SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr